Detalhe da pesquisa
1.
Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa.
Malar J
; 22(1): 215, 2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491295
2.
Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.
Ann Neurol
; 89(1): 91-98, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33016374
3.
Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study.
Eur Respir J
; 57(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855225
4.
Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE.
Ann Clin Microbiol Antimicrob
; 15: 18, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26976128
5.
Secukinumab Self-Administration by Prefilled Syringe Maintains Reduction of Plaque Psoriasis Severity Over 52 Weeks: Results of the FEATURE Trial.
J Drugs Dermatol
; 15(10): 1226-1234, 2016 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27741340
6.
Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database.
J Antimicrob Chemother
; 68(7): 1642-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23515247
7.
Daptomycin for the treatment of infective endocarditis: results from a European registry.
J Antimicrob Chemother
; 68(4): 936-42, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23190763
8.
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Lancet Infect Dis
; 23(9): 1051-1061, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327809
9.
Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents.
Pediatr Infect Dis J
; 35(5): 511-6, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26849158
10.
Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE).
Infect Dis Ther
; 4(3): 273-82, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26168987
11.
Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience.
Adv Ther
; 32(12): 1192-205, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26610384
12.
Daptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry.
Adv Ther
; 32(8): 715-26, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26239201
13.
Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE).
Infect Dis Ther
; 4(3): 283-96, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26168988
14.
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry.
Adv Ther
; 32(6): 496-509, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26108157
15.
Safety and efficacy of daptomycin as first-line treatment for complicated skin and soft tissue infections in elderly patients: an open-label, multicentre, randomized phase IIIb trial.
Drugs Aging
; 30(10): 829-36, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23990341
16.
52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B.
PLoS One
; 8(2): e54279, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23390496